As of 2026-10-04, the Fair Value of BetterLife Pharma Inc (BETR.CN) is -0.06 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.27 CAD, the upside of BetterLife Pharma Inc is -121.48%.
With the market price of 0.27 CAD and our fair value calculation, BetterLife Pharma Inc (BETR.CN) is not a good investment. Investing in BETR.CN stocks now will result in a potential loss of 121.48%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 5Y Avg | |
| Net income | -19.59 | -36.35 | -12.16 | -9.02 | -2.89 | -16.00 |
| YoY growth | -111.66% | -85.57% | 66.55% | 25.85% | 67.96% | -7.37% |
| Market Cap (mil) | 33.61 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | -7.37% |
| TTM earnings | -1.89 |